Paper Details

  1. Home
  2. Paper Details

Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact.

Author: AuroraSheena, BrinMitchell F, DienerHans-Christoph, DodickDavid W, LiptonRichard B, SilbersteinStephen D, TurkelCatherine C

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Chronic migraine (CM) is a debilitating condition with few effective treatments. OnabotulinumtoxinA became the first medication specifically approved for preventing headaches in CM. Two large studies showed that onabotulinumtoxinA significantly reduced the number of headache days compared to placebo. OnabotulinumtoxinA has been shown to be safe and effective in over 5,000 patients with CM, also improving quality of life, reducing mental health issues, and lowering healthcare use. Side effects are generally mild and tend to lessen over time.
Paper Details　
Original Abstract of the Article :
Chronic migraine (CM) is a neurological disease characterized by frequent migraine attacks that prevent affected individuals from performing daily activities of living, significantly diminish quality of life, and increase familial burden. Before onabotulinumtoxinA was approved for CM, there were few...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374186/

データ提供：米国国立医学図書館（NLM）

Botox for Chronic Migraine: A Game-Changer

The field of neurology has long grappled with the challenges of treating chronic migraine (CM), a debilitating condition that can significantly impact daily life. This study delves into the development and impact of onabotulinumtoxinA (Botox) as a preventative treatment for CM. The authors meticulously detail the clinical trials that led to the approval of Botox for CM, emphasizing the pivotal role it played in improving CM classification criteria. The research highlights the positive outcomes observed in clinical trials, demonstrating a substantial reduction in headache frequency and an improvement in quality of life for patients with CM. Additionally, the study sheds light on the safety and effectiveness of Botox, which has been established in thousands of patients across diverse populations.

Botox: A Beacon of Hope for Chronic Migraine Sufferers

The results of this study present compelling evidence of the efficacy and safety of Botox in managing chronic migraine. The significant reduction in headache frequency observed in patients treated with Botox compared to placebo offers a glimmer of hope for individuals who have long struggled with this debilitating condition. It is particularly encouraging to see that Botox has not only reduced headache frequency but also improved quality of life for patients, enabling them to participate more fully in daily activities. This finding is a testament to the transformative power of Botox in alleviating the burden of CM.

Living with Chronic Migraine: A New Perspective

For individuals battling chronic migraine, this study offers a renewed sense of optimism. While Botox is not a cure, it provides a viable and effective treatment option that can significantly improve quality of life. It is important to note that Botox is a preventative treatment, meaning it is not intended to treat acute migraine attacks. However, by reducing the frequency of headaches, Botox can empower individuals with CM to lead more fulfilling lives. The study highlights the importance of ongoing research and development in neurology, as it continues to uncover innovative treatments that can benefit patients with complex and challenging conditions.

Dr.Camel's Conclusion

This study is a remarkable testament to the progress made in the treatment of chronic migraine. Botox has emerged as a powerful tool in managing this debilitating condition, offering hope and a better quality of life to countless individuals. As a desert camel, I know a thing or two about harsh conditions, and Botox has provided relief just like a refreshing oasis in the midst of a relentless desert storm!

Date :
  1. Date Completed 2023-07-31
  2. Date Revised 2023-07-31
Further Info :

Pubmed ID

37499085

DOI: Digital Object Identifier

PMC10374186

Related Literature

Article Analysis
・Effective treatment of migraine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.